Archive for the ‘Nootropics’ tag
Adderall XR – chameleon
Attention.
Just one of the benefits of Adderall XR in ADHD
-Demonstrated significant improvement in attention
-Demonstrated significant improvement in performance
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Keppra
Keppra injection: the 1st and only 2nd generation injectable anticonvulsant
In the bag… without all the baggage:
No blood level monitoring required with Keppra
No loading dose required
No known clinically significant drug interactions
No reported incidence of purple glove syndrome in clinical studies
No special handling required for storage or vial
Levetiracetam (INN) is an anticonvulsant medication used to treat epilepsy. It is S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc.
Along with other anticonvulsants like gabapentin, it is also sometimes used to treat neuropathic pain.
Levetiracetam has recently been approved in the United Kingdom as a monotherapy treatment for epilepsy. It is also used in veterinary medicine for similar purposes.
Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, autism, and anxiety disorder, but its most serious adverse effects are behavioral and its benefit-risk ratio in these conditions is not well understood.
From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)
Brand name: Keppra
Generic name/category: Levetiracetam, anticonvulsants
Company: UCB
Country/Market: USA, North America
Indication(s)/use: treatment of partial onset seizures in adult with epilepsy
Target: Healthcare Professionals (HCP)
Tagline: A foundation of powerful therapy
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007
To see all of this brand's ads on AdPharm, click here
4 views
Aug 23, 2009
Visit AdPharm.net for more pharmaceutical ads
Keppra
Keppra injection: the 1st and only 2nd generation injectable anticonvulsant
In the bag… without all the baggage:
No blood level monitoring required with Keppra
No loading dose required
No known clinically significant drug interactions
No reported incidence of purple glove syndrome in clinical studies
No special handling required for storage or vial
Levetiracetam (INN) is an anticonvulsant medication used to treat epilepsy. It is S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc.
Along with other anticonvulsants like gabapentin, it is also sometimes used to treat neuropathic pain.
Levetiracetam has recently been approved in the United Kingdom as a monotherapy treatment for epilepsy. It is also used in veterinary medicine for similar purposes.
Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, autism, and anxiety disorder, but its most serious adverse effects are behavioral and its benefit-risk ratio in these conditions is not well understood.
From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)
Brand name: Keppra
Generic name/category: Levetiracetam, anticonvulsants
Company: UCB
Country/Market: USA, North America
Indication(s)/use: treatment of partial onset seizures in adult with epilepsy
Target: Healthcare Professionals (HCP)
Tagline: A foundation of powerful therapy
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007
To see all of this brand's ads on AdPharm, click here
2 views
Aug 23, 2009
